Tirzepatide is approved by the Food and Drug Administration (FDA) for treating type 2 diabetes and obesity, akin to other GLP ...

Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

A new weight loss treatment, Sirona, expands in the stomach to curb hunger. Phase 2 trials show promising results and the ...

HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

As part of this strategy, CordenPharma has finalized plans to establish a state-of-the-art peptide manufacturing facility in ...

Cambridge synthetic biology doyen Constructive Bio has been awarded a significant grant from Innovate UK to transform the ...

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...